• 1
    WHO Consultation on Obesity (2000) Obesity: Preventing and Managing the Global Epidemic World Health Organization Geneva, Switzerland.
  • 2
    National Center for Health Statistics (2001) Prevalence of Overweight and Obesity Among Adults: United States, 1999–2000 National Center for Health Statistics Washington, DC.
  • 3
    Flegal, K. M., Carroll, M. D., Ogden, C. L., Johnson, C. L. (2002) Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288: 17231727.
  • 4
    Mokdad, A. H., Bowman, B. A., Ford, E. S., Vinicor, F., Marks, J. S., Koplan, J. P. (2001) The continuing epidemics of obesity and diabetes in the United States. JAMA 286: 11951200.
  • 5
    McTigue, K. M., Garrett, J. M., Popkin, B. M. (2002) The natural history of the development of obesity in a cohort of young U.S. adults between 1981 and 1998. Ann Intern Med. 136: 857864.
  • 6
    Colditz, G. A. (1999) Economic costs of obesity and inactivity. Med Sci Sports Exerc. 31 (11 Suppl): S663S667.
  • 7
    U.S. Department of Health and Human Services (2001) The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General Rockville, MD.
  • 8
    Royal College of Physicians, Royal College of Paediatrics and Child Health and Faculty of Public Health (2004) Storing Up Problems: The Medical Case for a Slimmer Nation. Report of a Working Party RCP, RCPCH, and Faculty of Public Health London, UK.
  • 9
    Visscher, T. L., Seidell, J. C. (2001) The public health impact of obesity. Annu Rev Public Health 22: 355375.
  • 10
    NHLBI Expert Panel on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res. 6: (Suppl 2), 51S209S.
  • 11
    Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., Heath, C. W. Jr. (1999) Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 341: 10971105.
  • 12
    Field, A. E., Coakley, E. H., Must, A., et al. (2001) Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 161: 15811586.
  • 13
    Must, A., Spadano, J., Coakley, E. H., Field, A. E., Colditz, G., Dietz, W. H. (1999) The disease burden associated with overweight and obesity. JAMA 282: 15231529.
  • 14
    Rabkin, S. W., Chen, Y., Leiter, L., Liu, L., Reeder, B. A. (1997) Risk factor correlates of body mass index. Canadian Heart Health Surveys Research Group. Can Med Assoc J. 157: (Suppl 1), S26S31.
  • 15
    Pi-Sunyer, F. X. (1993) Medical hazards of obesity. Ann Intern Med. 119: 655660.
  • 16
    Mokdad, A. H., Marks, J. S., Stroup, D. F., Gerberding, J. L. (2004) Actual causes of death in the United States, 2000. JAMA 291: 12381245.
  • 17
    Willett, W. C., Manson, J. E., Stampfer, M. J., et al. (1995) Weight, weight change, and coronary heart disease in women. Risk within the ‘normal’ weight range. JAMA 273: 461465.
  • 18
    Manson, J. E., Willett, W. C., Stampfer, M. J., et al. (1995) Body weight and mortality among women. N Engl J Med. 333: 677685.
  • 19
    Harris, T. B., Launer, L. J., Madans, J., Feldman, J. J. (1997) Cohort study of effect of being overweight and change in weight on risk of coronary heart disease in old age. BMJ 314: 17911794.
  • 20
    Jeffery, R. W., Drewnowski, A., Epstein, L. H., et al. (2000) Long-term maintenance of weight loss: current status. Health Psychol. 19 (1 Suppl): 516.
  • 21
    Goldstein, D. J. (1992) Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord. 16: 397415.
  • 22
    Chisholm, D. J., Samaras, K., Markovic, T., Carey, D., Lapsys, N., Campbell, L. V. (1998) Obesity: genes, glands or gluttony? Reprod Fertil Dev. 10: 4953.
  • 23
    Senekal, M., Albertse, E. C., Momberg, D. J., Groenewald, C. J., Visser, E. M. (1999) A multidimensional weight-management program for women. J Am Diet Assoc. 99: 12571264.
  • 24
    Glenny, A. M., O'Meara, S., Melville, A., Sheldon, T. A., Wilson, C. (1997) The treatment and prevention of obesity: a systematic review of the literature. Int J Obes Relat Metab Disord. 21: 715737.
  • 25
    Lau, D. C. (1999) Call for action: preventing and managing the expansive and expensive obesity epidemic. Can Med Assoc J. 160: 503506.
  • 26
    Weinstein, M. C., Toy, E. L., Sandberg, E. A., et al. (2001) Modeling for health care and other policy decisions: uses, roles, and validity. Value Health. 4: 348361.
  • 27
    Gregg, E. W., Gerzoff, R. B., Thompson, T. J., Williamson, D. F. (2003) Intentional weight loss and death in overweight and obese U.S. adults 35 years of age and older. Ann Intern Med. 138: 383389.
  • 28
    Gold M. R., Siegel J. E., Russell, L. B., Weinstein, M. C. eds (1996). Cost-Effectiveness in Health and Medicine Oxford University Press New York, NY.
  • 29
    American Heart Association (2000) The American Heart Association Eating Plan for Healthy Americans American Heart Association Dallas, TX.
  • 30
    American Heart Association (1994) American Heart Association Guidelines for Weight Management Programs for Healthy Adults American Heart Association Dallas, TX.
  • 31
    Halpern, E. F., Weinstein, M. C., Hunink, M. G., Gazelle, G. S. (2000) Representing both first-and second-order uncertainties by Monte Carlo simulation for groups of patients. Med Decis Making 20: 314322.
  • 32
    National Center for Health Statistics (1994) Plan and operation of the Third National Health and Nutrition Examination Survey, 1988–94. Vital Health Stat 1. 32: 1407.
  • 33
    Macdonald, S. M., Reeder, B. A., Chen, Y., Despres, J. P. (1997) Obesity in Canada: a descriptive analysis. Canadian Heart Health Surveys Research Group. Can Med Assoc J. 157: (Suppl 1), S3S9.
  • 34
    Phelan, S., Wadden, T. A. (2002) Combining behavioral and pharmacological treatments for obesity. Obes Res. 10: 560574.
  • 35
    Lowe, M. R., Miller-Kovach, K., Phelan, S. (2001) Weight loss maintenance in overweight individuals one to five years following successful completion of a commercial weight loss program. Int J Obes Relat Metab Disord. 25: 325331.
  • 36
    Anderson, J. W., Vichitbandra, S., Qian, W., Kryscio, R. J. (1999) Long-term weight maintenance after an intensive weight-loss program. J Am Coll Nutr. 18: 620627.
  • 37
    Gosselin, C., Cote, G. (2001) Weight loss maintenance in women two to eleven years after participating in a commercial program: a survey. BMC Womens Health 1: 2
  • 38
    McGuire, M. T., Wing, R. R., Hill, J. O. (1999) The prevalence of weight loss maintenance among American adults. Int J Obes Relat Metab Disord. 23: 13141319.
  • 39
    Anderson, J. W., Konz, E. C., Frederich, R. C., Wood, C. L. (2001) Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 74: 579584.
  • 40
    Wing, R. R., Hill, J. O. (2001) Successful weight loss maintenance. Annu Rev Nutr. 21: 323341.
  • 41
    Wood, P. D., Stefanick, M. L., Williams, P. T., Haskell, W. L. (1991) The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med. 325: 461466.
  • 42
    Svendsen, O. L., Hassager, C., Christiansen, C. (1993) Effect of an energy-restrictive diet, with or without exercise, on lean tissue mass, resting metabolic rate, cardiovascular risk factors, and bone in overweight postmenopausal women. Am J Med. 95: 131140.
  • 43
    Stefanick, M. L., Mackey, S., Sheehan, M., Ellsworth, N., Haskell, W. L., Wood, P. D. (1998) Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N Engl J Med. 339: 1220.
  • 44
    Gordon, N. F., Scott, C. B., Levine, B. D. (1997) Comparison of single versus multiple lifestyle interventions: are the antihypertensive effects of exercise training and diet-induced weight loss additive? Am J Cardiol. 79: 763767.
  • 45
    Wing, R. R., Jeffery, R. W. (1995) Effect of modest weight loss on changes in cardiovascular risk factors: are there differences between men and women or between weight loss and maintenance? Int J Obes Relat Metab Disord. 19: 6773.
  • 46
    Wing, R. R., Venditti, E., Jakicic, J. M., Polley, B. A., Lang, W. (1998) Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Care 21: 350359.
  • 47
    Andersen, R. E., Wadden, T. A., Bartlett, S. J., Vogt, R. A., Weinstock, R. S. (1995) Relation of weight loss to changes in serum lipids and lipoproteins in obese women. Am J Clin Nutr. 62: 350357.
  • 48
    Davidson, M. H., Hauptman, J., DiGirolamo, M., et al. (1999) Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial [see comments]. JAMA 281: 235242.
  • 49
    Skender, M. L., Goodrick, G. K., Del Junco, D. J., et al. (1996) Comparison of 2-year weight loss trends in behavioral treatments of obesity: diet, exercise, and combination interventions. J Am Diet Assoc. 96: 342346.
  • 50
    Wadden, T. A., Vogt, R. A., Foster, G. D., Anderson, D. A. (1998) Exercise and the maintenance of weight loss: 1-year follow-up of a controlled clinical trial. J Consult Clin Psychol. 66: 429433.
  • 51
    Rippe, J. M., Price, J. M., Hess, S. A., et al. (1998) Improved psychological well-being, quality of life, and health practices in moderately overweight women participating in a 12-week structured weight loss program. Obes Res. 6: 208218.
  • 52
    Andersen, R. E., Wadden, T. A., Bartlett, S. J., Zemel, B., Verde, T. J., Franckowiak, S. C. (1999) Effects of lifestyle activity vs structured aerobic exercise in obese women: a randomized trial. JAMA 281: 335340.
  • 53
    Wadden, T. A., Vogt, R. A., Andersen, R. E., et al. (1997) Exercise in the treatment of obesity: effects of four interventions on body composition, resting energy expenditure, appetite, and mood. J Consult Clin Psychol. 65: 269277.
  • 54
    Sjöström, L., Rissanen, A., Andersen, T., et al. (1998) Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group. Lancet 352: 167172.
  • 55
    Karhunen, L., Franssila-Kallunki, A., Rissanen, P., et al. (2000) Effect of orlistat treatment on body composition and resting energy expenditure during a two-year weight-reduction programme in obese Finns. Int J Obes Relat Metab Disord. 24: 15671572.
  • 56
    Finer, N., James, W. P., Kopelman, P. G., Lean, M. E., Williams, G. (2000) One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. Int J Obes Relat Metab Disord. 24: 306313.
  • 57
    Rossner, S., Sjöström, L., Noack, R., Meinders, A. E., Noseda, G. (2000) Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group. Obes Res. 8: 4961.
  • 58
    Zavoral, J. H. (1998) Treatment with orlistat reduces cardiovascular risk in obese patients. J Hypertens. 16: 20132017.
  • 59
    Hill, J. O., Hauptman, J., Anderson, J. W., et al. (1999) Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. Am J Clin Nutr. 69: 11081116.
  • 60
    Fox, A. A., Thompson, J. L., Butterfield, G. E., Gylfadottir, U., Moynihan, S., Spiller, G. (1996) Effects of diet and exercise on common cardiovascular disease risk factors in moderately obese older women. Am J Clin Nutr. 63: 225233.
  • 61
    Jakicic, J. M., Winters, C., Lang, W., Wing, R. R. (1999) Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss, and fitness in overweight women: a randomized trial. JAMA 282: 15541560.
  • 62
    Wadden, T. A., Berkowitz, R. I., Sarwer, D. B., Prus-Wisniewski, R., Steinberg, C. (2001) Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial. Arch Intern Med. 161: 218227.
  • 63
    Thomson, M. E., Kramer, M. S. (1984) Methodologic standards for controlled clinical trials of early contact and maternal-infant behavior. Pediatrics 73: 294300.
  • 64
    Colditz, G. A., Willett, W. C., Stampfer, M. J., et al. (1990) Weight as a risk factor for clinical diabetes in women. Am J Epidemiol. 132: 501513.
  • 65
    Gorsky, R. D., Pamuk, E., Williamson, D. F., Shaffer, P. A., Koplan, J. P. (1996) The 25-year health care costs of women who remain overweight after 40 years of age. Am J Prev Med. 12: 388394.
  • 66
    Anderson, K. M., Wilson, P. W., Odell, P. M., Kannel, W. B. (1991) An updated coronary risk profile. A statement for health professionals. Circulation 83: 356362.
  • 67
    Avins, A. L., Browner, W. S. (1998) Improving the prediction of coronary heart disease toaid in the management of high cholesterol levels: what a difference a decade makes. JAMA 279: 445449.
  • 68
    Clinical Diagnostic Laboratory Fee Schedule: Public File (2001) http:www.kansasmedicare.compart_ApartA_formslabfs2001forwebsite.pdf (Accessed June 6, 2006).
  • 69
    2001 Physician Fee Schedule and Non-Physician Practitioner Fee Schedule Relative Value File. Federal Register, Vol. 65, No. 212, November 1 (2000) http:www.access.gpo.govsu_docsfedrega001101c.htm (Accessed June 6, 2006).
  • 70
    Berke, E. M., Morden, N. E. (2000) Medical management of obesity. Am Fam Phys. 62: 419426.
  • 71
    Thompson, D., Edelsberg, J., Colditz, G. A., Bird, A. P., Oster, G. (1999) Lifetime health and economic consequences of obesity. Arch Intern Med. 159: 21772183.
  • 72
    Nyman, J. A., Martinson, M. S., Nelson, D., et al. (2002) Cost-effectiveness of gemfibrozil for coronary heart disease patients with low levels of high-density lipoprotein cholesterol: the Department of Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial. Arch Intern Med. 162: 177182.
  • 73
    American Heart Association (2001) Heart and Stroke 2002 Statistical Update American Heart Association Dallas, TX.
  • 74
    Kuntz, K. M., Fleischmann, K. E., Hunink, M. G., Douglas, P. S. (1999) Cost-effectiveness of diagnostic strategies for patients with chest pain. Ann Intern Med. 130: 709718.
  • 75
    Weinstein, M. C., Manning, W. G. Jr (1997) Theoretical issues in cost-effectiveness analysis. J Health Econ. 16: 121128.
  • 76
    Meltzer, D., Egleston, B., Stoffel, D., Dasbach, E. (2000) Effect of future costs on cost-effectiveness of medical interventions among young adults: the example of intensive therapy for type 1 diabetes mellitus. Medical Care. 38: 679685.
  • 77
    Meltzer, D. (1997) Accounting for future costs in medical cost-effectiveness analysis. J Health Econ. 16: 3364.
  • 78
    Johannesson, M., Meltzer, D., O'Conor, R. M. (1997) Incorporating future costs in medical cost-effectiveness analysis: implications for the cost-effectiveness of the treatment of hypertension. Med Decis Making 17: 382389.
  • 79
    Thompson, S., Wordsworth, S. (2001) An Annotated Cost Questionnaire for Completion by Patients University of Aberdeen, Health Economics Research Unit Aberdeen, UK.
  • 80
    America Automotive Association (2001) 2001 National Average Costs per Mile to Operate Personal Vehicle http:www.aaasouth.comacs_newsDriveco2.asp (Accessed September 30, 2001).
  • 81
    U.S. Bureau of Labor Statistics (2001) National Compensation Survey: Occupational Wages in the United States, 2001 US Government Printing Office Washington, DC.
  • 82
    National Center for Health Statistics (2001) Statistical Abstract of the United States: Consumer Price Index: All Urban Consumers National Center for Health Statistics Washington, DC.
  • 83
    Fryback, D. G., Dasbach, E. J., Klein, R., et al. (1993) The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors. Med Decis Making 13: 89102.
  • 84
    McLellan, F. (2002) Obesity rising to alarming levels around the world. Lancet 359: 1412
  • 85
    Friedrich, M. J. (2002) Epidemic of obesity expands its spread to developing countries. JAMA 287: 13821386.
  • 86
    Wadden, T. A., Brownell, K. D., Foster, G. D. (2002) Obesity: responding to the global epidemic. J Consult Clin Psychol. 70: 510525.
  • 87
    No authors listed (2002) Getting a handle on obesity. Lancet 359: 1955
  • 88
    NHS Centre for Reviews and Dissemination, University of York (Accessed January 30, 2003) Bulletin on the Effectiveness of Health Service Interventions for Decision Makers: The Prevention and Treatment of Obesity
  • 89
    Fontaine, K. R., Bartlett, S. J., Barofsky, I. (2000) Health-related quality of life among obese persons seeking and not currently seeking treatment. Int J Eat Disord. 27: 101105.
  • 90
    Fontaine, K. R., Bartlett, S. J. (1998) Estimating health-related quality of life in obese individuals. Dis Manage Health Outcomes 3: 6170.
  • 91
    Heo, M., Allison, D. B., Faith, M. S., Zhu, S., Fontaine, K. R. (2003) Obesity and quality of life: mediating effects of pain and comorbidities. Obes Res. 11: 209216.
  • 92
    Peeters, A., Barendregt, J. J., Willekens, F., Mackenbach, J. P., Al Mamun, A., Bonneux, L. (2003) Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 138: 2432.
  • 93
    Ford, E. S., Moriarty, D. G., Zack, M. M., Mokdad, A. H., Chapman, D. P. (2001) Self-reported body mass index and health-related quality of life: findings from the Behavioral Risk Factor Surveillance System. Obes Res. 9: 2131.
  • 94
    Fine, J. T., Colditz, G. A., Coakley, E. H., et al. (1999) A prospective study of weight change and health-related quality of life in women. JAMA 282: 21362142.
  • 95
    Oster, G., Thompson, D., Edelsberg, J., Bird, A. P., Colditz, G. A. (1999) Lifetime health and economic benefits of weight loss among obese persons. Am J Public Health 89: 15361542.
  • 96
    O'Meara, S., Riemsma, R., Shirran, L., Mather, L., ter Riet, G. (2001) A rapid and systematic review of the clinical effectiveness and cost-effectiveness of orlistat in the management of obesity. Health Technol Assess. 5: 181.
  • 97
    O'Meara, S., Riemsma, R., Shirran, L., Mather, L., ter Riet, G. (2002) The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment. Health Technol Assess. 6: 197.
  • 98
    No authors listed (1998) The cost-effectiveness of screening for type 2 diabetes. CDC Diabetes Cost-Effectiveness Study Group, Centers for Disease Control and Prevention. JAMA 280: 17571763.
  • 99
    Salkeld, G., Phongsavan, P., Oldenburg, B. (1997) The cost-effectiveness of a cardiovascular risk reduction program in general practice. Health Policy 41: 105119.
  • 100
    Hatziandreu, E. I., Koplan, J. P., Weinstein, M. C., Caspersen, C. J., Warner, K. E. (1988) A cost-effectiveness analysis of exercise as a health promotion activity. Am J Public Health 78: 14171421.
  • 101
    U.S. Preventive Services Task Force (2002) Behavioral counseling in primary care to promote physical activity: recommendation and rationale. Ann Intern Med. 137: 205207.
  • 102
    Calle, E. E., Rodriguez, C., Walker-Thurmond, K., Thun, M. J. (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 348: 16251638.
  • 103
    Hypertension Prevention Collaborative Research Group (1997) Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, Phase II. Arch Intern Med. 157: 657667.
  • 104
    Ewbank, P. P., Darga, L. L., Lucas, C. P. (1995) Physical activity as a predictor of weight maintenance in previously obese subjects. Obes Res. 3: 257263.
  • 105
    Perri, M., Fuller, P. (1995) Success and failure in the treatment of obesity: where do we go from here? Med Exer Nutr Health 4: 255272.
  • 106
    Safer, D. J. (1991) Diet, behavior modification, and exercise: a review of obesity treatments from a long-term perspective. South Med J. 84: 14701474.
  • 107
    Anderson, R. N. (2001) United States Life Tables, 1998. Natl Vital Stat Rep. 48: 39
  • 108
    Col, N. F., Eckman, M. N., Karas, R. H., et al. (1997) Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA 277: 11401147.
  • 109
    2001 Program for Weight Management: Program Costs (2001) Brigham and Women's Hospital Boston, MA http:www.brighamandwomens.orgweightmanagementprogramcosts.asp (Accessed October 15, 2001).
  • 110
    Harris, R. A., Nease, R. F. Jr (1997) The importance of patient preferences for comorbidities in cost-effectiveness analyses. J Health Econ. 16: 113119.